Keyphrases
Prostate Cancer
79%
Benign Prostatic Hyperplasia
62%
Erectile Dysfunction
51%
Prostate
47%
Brachytherapy
47%
Melatonin
47%
Prostate-specific Antigen
36%
Alfuzosin
36%
Sildenafil
32%
Melatonin Receptors
29%
Lower Urinary Tract Symptoms
28%
Benign Prostatic Hypertrophy
27%
Prostate Epithelial Cells
27%
Once-daily
26%
Sexual Behavior
26%
Erectile Function
25%
Elderly People
24%
Prostate Cancer Patients
24%
Israel Defense Forces
23%
Israel
22%
Iodine-125 Brachytherapy
22%
Acute Urinary Retention
21%
Ureter
21%
Localized Prostate Cancer
21%
Benign Prostate Disease
21%
Gonadotropin-releasing Hormone
20%
Prostate Carcinoma
20%
Clinical Significance
19%
Urologists
18%
Finasteride
18%
RigiScan
17%
Hypoxia-inducible factor-1α (HIF-1α)
17%
Total Prostate-specific Antigen
17%
Prostatic Carcinoma
17%
Prognostic Factors
17%
Tumor
17%
Pediatric
17%
International Prostate Symptom Score
17%
Intraoperative Planning
16%
125I
16%
Percutaneous Nephrolithotomy
16%
Testosterone
16%
Operative Time
15%
Indwelling Catheter
15%
Epidemiological Characteristics
15%
Follicle-stimulating Hormone
15%
Supine Percutaneous Nephrolithotomy
15%
Prostate Brachytherapy
15%
Renal Scan
15%
Sexual Dysfunction
15%
Medicine and Dentistry
Prostate Cancer
100%
Brachytherapy
66%
Prostate Hypertrophy
55%
Percutaneous Nephrolithotomy
46%
Symptom
38%
Erectile Dysfunction
38%
Urinary Retention
35%
Iodine 125
32%
Sildenafil
32%
Lower Urinary Tract Symptom
30%
Urinary System
28%
Alfuzosin
26%
Disease
25%
Prognostic Factor
21%
Biopsy
21%
External Beam Radiotherapy
21%
Bladder Cancer
20%
Transurethral Resection
20%
Prostate Specific Antigen
20%
Nephrostomy
19%
Prostatectomy
19%
Urologist
18%
Pediatrics
17%
Prospective Study
17%
Bladder
17%
International Prostate Symptom Score
16%
Nephrectomy
15%
Benign Prostatic Hyperplasia
15%
Urethroplasty
15%
Dosimetry
15%
Radioisotope Renography
15%
Hyperthermia
15%
Androgen
14%
Operation Duration
14%
Analgesia
14%
Antiandrogen
13%
Bladder Tumor
13%
International Index of Erectile Function
12%
Ureter
12%
Hormone Therapy
12%
Neoplasm
12%
Obstruction
11%
Phallus
11%
Prostate Biopsy
11%
Combination Therapy
11%
Peyronie's Disease
11%
Multivariate Analysis
11%
Monotherapy
11%
Ureter Stricture
11%
Computer Assisted Tomography
11%